{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:26:20Z","timestamp":1790745980757,"version":"4.1.0"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00794","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T14:45:02Z","timestamp":1574433902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":63,"title":["Neuromuscular Diseases and Bone"],"prefix":"10.3389","volume":"10","author":[{"given":"Giovanni","family":"Iolascon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paoletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Curci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antimo","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11021","DOI":"10.1074\/jbc.M116.770941","article-title":"Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: a novel mechanism in muscle-bone communication","volume":"292","author":"Qin","year":"2017","journal-title":"J Biol Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1038\/s41598-017-02557-8","article-title":"Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice","volume":"7","author":"Colaianni","year":"2017","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12157","DOI":"10.1073\/pnas.1516622112","article-title":"The myokine irisin increases cortical bone mass","volume":"112","author":"Colaianni","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.celrep.2018.01.041","article-title":"\u03b2-aminoisobutyric Acid, l-BAIBA, is a muscle-derived osteocyte survival factor","volume":"22","author":"Kitase","year":"2018","journal-title":"Cell Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"16042","DOI":"10.1073\/pnas.1514250112","article-title":"Musclin is an activity-stimulated myokine that enhances physical endurance","volume":"112","author":"Subbotina","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B6","first-page":"1993","article-title":"Inclusion body myopathy with paget disease of bone and\/or frontotemporal Dementia","volume-title":"GeneReviews","author":"Kimonis","year":"2007"},{"key":"B7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1359\/jbmr.080218","article-title":"Genetics of the musculoskeletal system: a pleiotropic approach","volume":"23","author":"Karasik","year":"2008","journal-title":"J Bone Miner Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2013a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3233\/JND-140045","article-title":"The epidemiology of neuromuscular disorders: a comprehensive overview of the literature","volume":"2","author":"Deenen","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mus.23942","article-title":"Cost of illness for neuromuscular diseases in the United States","volume":"49","author":"Larkindale","year":"2014","journal-title":"Muscle Nerve."},{"key":"B12","unstructured":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J Rare Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.nmd.2017.01.019","article-title":"Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity","volume":"27","author":"Wasserman","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00198-016-3774-5","article-title":"The time to and determinants of first fractures in boys with Duchenne muscular dystrophy","volume":"28","author":"Ma","year":"2017","journal-title":"Osteoporos Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve."},{"key":"B17","doi-asserted-by":"publisher","first-page":"41035","DOI":"10.1074\/jbc.M100233200","article-title":"Osteoclast-stimulating factor interacts with the spinal muscular atrophy gene product to stimulate osteoclast formation","volume":"276","author":"Kurihara","year":"2001","journal-title":"J Biol Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0883073807305664","article-title":"Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling","volume":"22","author":"Shanmugarajan","year":"2007","journal-title":"J Child Neurol."},{"key":"B19","first-page":"1993","article-title":"Spinal muscular atrophy","volume-title":"GeneReviews","author":"Prior","year":"2000"},{"key":"B20","first-page":"105","article-title":"Type 0 spinal muscular atrophy in rare association with congenital contracture and generalized osteopenia","volume":"12","author":"Singh","year":"2018","journal-title":"Iran J Child Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.nmd.2019.06.001","article-title":"Evolution of bone mineral density, bone metabolism and fragility fractures in Spinal Muscular Atrophy (SMA) types 2 and 3","volume":"29","author":"Baranello","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"B22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bone.2015.05.039","article-title":"Bone and spinal muscular atrophy","volume":"79","author":"Vai","year":"2015","journal-title":"Bone"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6509493","DOI":"10.1155\/2017\/6509493","article-title":"Inherited paediatric motor neuron disorders: beyond spinal muscular atrophy","volume":"2017","author":"Teoh","year":"2017","journal-title":"Neural Plast"},{"key":"B24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2106\/JBJS.I.00281","article-title":"Arthrogryposis: a review and update","volume":"91","author":"Bamshad","year":"2009","journal-title":"J Bone Joint Surg Am."},{"key":"B25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ajhg.2016.01.006","article-title":"Mutations in subunits of the activating signal cointegrator 1 complex are associated with prenatal spinal muscular atrophy and congenital bone fractures","volume":"98","author":"Knierim","year":"2016","journal-title":"Am J Hum Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/WCO.0b013e328364c04b","article-title":"The various Charcot-Marie-Tooth diseases","volume":"26","author":"Vallat","year":"2013","journal-title":"Curr Opin Neurol."},{"key":"B27","article-title":"Charcot-Marie-Tooth (CMT) hereditary neuropathy overview","author":"Bird","year":"1998","journal-title":"GeneReviews"},{"key":"B28","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/mus.24240","article-title":"Risk of fracture in patients with Charcot-Marie-Tooth disease","volume":"50","author":"Pouwels","year":"2014","journal-title":"Muscle Nerve."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1212\/WNL.0000000000000804","article-title":"Increased risk of osteoporosis in patients with myasthenia gravis: a population-based cohort study","volume":"83","author":"Yeh","year":"2014","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"Neuroinflammation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0139520","DOI":"10.1371\/journal.pone.0139520","article-title":"Tumor necrosis factor alpha and insulin-like growth factor 1 induced modifications of the gene expression kinetics of differentiating skeletal muscle cells","volume":"10","author":"Meyer","year":"2015","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","article-title":"A genome-wide association study of myasthenia gravis","volume":"72","author":"Renton","year":"2015","journal-title":"JAMA Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s00198-017-4041-0","article-title":"Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study","volume":"28","author":"Guan","year":"2017","journal-title":"Osteoporosis Int"},{"key":"B36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.spen.2017.04.003","article-title":"Pediatric Myasthenia Gravis","volume":"24","author":"Peragallo","year":"2017","journal-title":"Sem Pediatr Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/pd.492","article-title":"Hypoechogenicity of fetal long bones: a new ultrasound marker for arthrogryposis","volume":"22","author":"Murphy","year":"2002","journal-title":"Prenat Diagn"},{"key":"B38","article-title":"Dystrophinopathies, dystrophinopathies","author":"Darras","year":"2000","journal-title":"GeneReviews"},{"key":"B39","doi-asserted-by":"publisher","first-page":"485376","DOI":"10.1155\/2012\/485376","article-title":"Muscular dystrophies at different ages: metabolic and endocrine alterations","volume":"2012","author":"Guzm\u00e1n","year":"2012","journal-title":"Int J Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2353\/ajpath.2009.090052","article-title":"Myotendinous junction defects and reduced force transmission in mice that lack alpha7 integrin and utrophin","volume":"175","author":"Welser","year":"2009","journal-title":"Am J Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpn.2013.08.008","article-title":"Growth and psycomotor development of patients with Duchenne muscular dystrophy","volume":"18","author":"Sarrazin","year":"2014","journal-title":"Eur J Pediatr Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4172\/2161-0665.1000252","article-title":"Bone health in children with duchenne muscular dystrophy: a review","volume":"5","author":"Perera","year":"2015","journal-title":"Pediat Therapeut."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2019.07.002","article-title":"The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: the 2019 official pediatric positions of the ISCD","author":"Weber","year":"2019","journal-title":"J Clin Densitom"},{"key":"B45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/PRM-140282","article-title":"Bone health in children with neuromuscular disorders","volume":"7","author":"Ness","year":"2014","journal-title":"J Pediatr Rehabil Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/BPO.0000000000000348","article-title":"Risk factors for first fractures among males with duchenne or becker muscular dystrophy","volume":"35","author":"James","year":"","journal-title":"J Pediatr Orthopaed."},{"key":"B47","doi-asserted-by":"publisher","first-page":"928385","DOI":"10.1155\/2015\/928385","article-title":"optimizing bone health in duchenne muscular dystrophy","volume":"2015","author":"Buckner","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nmd.2018.09.005","article-title":"Fractures and bone health monitoring in boys with Duchenne muscular dystrophy managed within the Scottish Muscle Network","volume":"29","author":"Joseph","year":"2019","journal-title":"Neuromuscul Disord."},{"key":"B49","volume-title":"Textbook of Pediatric Rheumatology, 7","author":"Petty","year":"2016"},{"key":"B50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"DMD Care Considerations Working Group, Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4602129","DOI":"10.1155\/2017\/4602129","article-title":"Male hypogonadism and osteoporosis: the effects, clinical consequences, and treatment of testosterone deficiency in bone health","volume":"2017","author":"Golds","year":"2017","journal-title":"Int J Endocrinol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00431-019-03336-5","article-title":"Skeletal disproportion in glucocorticoid-treated boys with Duchenne muscular dystrophy","volume":"178","author":"Kao","year":"2019","journal-title":"Eur J Pediatr."},{"key":"B53","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1210\/er.2014-1024","article-title":"Sex steroid actions in male bone","volume":"35","author":"Vanderschueren","year":"2014"},{"key":"B54","first-page":"3389","article-title":"Glycogen storage disease type II: acid alphaglucosidase (acid maltase) deficiency","volume-title":"The Metabolic and Molecular Bases of Inherited Disease.","author":"Hirschhorn","year":"2001"},{"key":"B55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/CND.0b013e318176dbe4","article-title":"Pompe disease: a review of the current diagnosis and treatment recommendations in the Era of enzyme replacement therapy","volume":"9","author":"Katzin","year":"2008","journal-title":"J Clin Neuromusc Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bone.2010.06.021","article-title":"Low bone mass in Pompe disease: muscular strength as a predictor of bone mineral density","volume":"47","author":"van den Berg","year":"2010","journal-title":"Bone"},{"key":"B58","unstructured":"van den BergLEM\n          The Musculoskeletal System in Pompe Disease: Pathology, Consequences and Treatment Options2014"},{"key":"B59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/01.gim.0000217789.14470.c5","article-title":"Physical therapy management of Pompe disease","volume":"8","author":"Case","year":"2006","journal-title":"Genet Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/8904_2012_146","article-title":"In vivo bone architecture in Pompe disease using high-resolution peripheral computed tomography","volume":"7","author":"Khan","year":"2013","journal-title":"JIMD Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1210\/jc.2014-2763","article-title":"Prevalence of asymptomatic vertebral fractures in late-onset pompe disease","volume":"100","author":"Bertoldo","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"599","DOI":"10.5812\/ijem.4967","article-title":"Bone density in patients with late onset pompe disease","volume":"10","author":"Papadimas","year":"2012","journal-title":"Int J Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13104-017-2681-y","article-title":"Improvement of bone mineral density after enzyme replacement therapy in Chinese late-onset Pompe disease patients","volume":"10","author":"Sheng","year":"2017","journal-title":"BMC Res Notes."},{"key":"B64","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","article-title":"2013 Pediatric Position Development Conference: executive summary and reflections","volume":"17","author":"Gordon","year":"2014","journal-title":"J Clin Densitom."},{"key":"B65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejpn.2017.08.001","article-title":"Basics of bone metabolism and osteoporosis in common pediatric neuromuscular disabilities","volume":"22","author":"Yasar","year":"2018","journal-title":"Eur J Paediatr Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"Scientific Advisory Council of Osteoporosis Canada; 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary","volume":"182","author":"Papaioannou","year":"2010","journal-title":"CMAJ"},{"key":"B67","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","article-title":"Executive summary of the 2015 ISCD position development conference on advanced measures From DXA and QCT: fracture prediction beyond BMD","volume":"18","author":"Shepherd","year":"2015","journal-title":"J Clin Densitom."},{"key":"B68","first-page":"261","article-title":"Diagnosis and management of osteoporosis","volume":"92","author":"Jeremiah","year":"2015","journal-title":"Am Fam Physician."},{"key":"B69","unstructured":"WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level: Summary Meeting Report2019"},{"key":"B70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"SMA Care Group, Diagnosis and management of spinal muscular atrophy: Part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord."},{"key":"B71","article-title":"An overview of glucocorticoid induced osteoporosis","author":"Ilias","year":"2018","journal-title":"Endotext"},{"key":"B72","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"the AANEM consensus committee on late-onset pompe disease, consensus treatment recommendations for late-onset pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve."},{"key":"B74","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/nu9060594","article-title":"Nutritional challenges in duchenne muscular dystrophy","volume":"9","author":"Salera","year":"2017","journal-title":"Nutrients"},{"key":"B75","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.nmd.2008.02.008","article-title":"Feeding problems and malnutrition in spinal muscular atrophy type II","volume":"18","author":"Messina","year":"2008","journal-title":"Neuromuscul. Disord"},{"key":"B76","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.nmd.2011.02.006","article-title":"Endocrine aspect of Duchenne muscular dystrophy","volume":"21","author":"Bianchi","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1210\/jc.2011-0385","article-title":"Endocrine society. evaluation, treatment, and prevention of vitamin d deficiency: an endocrine society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"Clin Endocrinol Metab"},{"key":"B78","first-page":"365","article-title":"Committee to Review Dietary Reference Intakes for Vitamin D and Calcium","volume-title":"Dietary Reference Intakes for Calcium and Vitamin D","author":"Ross","year":"2011"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2333794X19835661","DOI":"10.1177\/2333794X19835661","article-title":"Increased rates of Vitamin D insufficiency in boys with duchenne muscular dystrophy despite higher Vitamin D3 supplementation","volume":"6","author":"Bian","year":"2019","journal-title":"Glob Pediatr Health"},{"key":"B80","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00198-010-1275-5","article-title":"Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment","volume":"22","author":"Bianchi","year":"2011","journal-title":"Osteoporos Int"},{"key":"B81","doi-asserted-by":"publisher","first-page":"676","DOI":"10.23736\/S1973-9087.17.04533-6","article-title":"Can vitamin D deficiency influence muscle performance in postmenopausal women? A multicenter retrospective study","volume":"54","author":"Iolascon","year":"2018","journal-title":"Eur J Phys Rehabil Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s12325-017-0492-0","article-title":"Effectiveness of calcifediol in improving muscle function in post-menopausal women: a prospective cohort study","volume":"34","author":"Iolascon","year":"2017","journal-title":"Adv Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jocn.2013.01.011","article-title":"Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis","volume":"20","author":"Karam","year":"2013","journal-title":"J Clin Neurosci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"35","DOI":"10.11138\/FNeur\/2017.32.1.035","article-title":"VitaminD in amyotrophic lateral sclerosis","volume":"32","author":"Libonati","year":"2017","journal-title":"Funct. Neurol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0140-6736(63)91031-6","article-title":"Disuse osteoporosis","volume":"48","author":"Takata","year":"2001","journal-title":"J Med Investig."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","article-title":"The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int."},{"key":"B87","volume-title":"Global Recommendations on Physical Activity for Health.","year":"2010"},{"key":"B88","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/0883073816685506","article-title":"Physical activity in boys with duchenne muscular dystrophy is lower and less demanding compared to healthy boys","volume":"32","author":"Heutinck","year":"2017","journal-title":"J Child Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e21822","DOI":"10.1371\/journal.pone.0021822","article-title":"Actigraph accelerometer-defined boundaries for sedentary behaviour and physical activity intensities in 7 year old children","volume":"6","author":"Pulsford","year":"2011","journal-title":"PLoS ONE"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1080\/02640410802334196","article-title":"Calibration of two objective measures of physical activity for children","volume":"26","author":"Evenson","year":"2008","journal-title":"J Sports Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1249\/MSS.0b013e3181c619b2","article-title":"Early physical activity provides sustained bone health benefits later in childhood","volume":"42","author":"Janz","year":"2010","journal-title":"Med Sci Sports Exerc."},{"key":"B92","doi-asserted-by":"publisher","first-page":"CD010899","DOI":"10.1002\/14651858.CD010899.pub2","article-title":"Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy","volume":"1","author":"Bell","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.pmr.2012.06.001","article-title":"Exercise in neuromuscular diseases","volume":"23","author":"Abresch","year":"2012","journal-title":"Phys Med Rehabil Clin N Am."},{"key":"B94","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2431-10-55","article-title":"Physical training in boys with Duchenne muscular dystrophy: the protocol of the No Use is Disuse study","volume":"10","author":"Jansen","year":"2010","journal-title":"BMC Pediatr."},{"key":"B95","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ped.12428","article-title":"Effect of muscle weakness distribution on balance in neuromuscular disease","volume":"57","author":"Kaya","year":"2015","journal-title":"Pediatr Int."},{"key":"B96","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"B97","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jbmr.237","article-title":"Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone","volume":"26","author":"Merlotti","year":"2011","journal-title":"J Bone Miner Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1359\/jbmr.070704","article-title":"Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone","volume":"22","author":"Merlotti","year":"2007","journal-title":"J Bone Miner Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"CD005088","DOI":"10.1002\/14651858.CD005088.pub4","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B100","doi-asserted-by":"publisher","first-page":"CD010429","DOI":"10.1002\/14651858.CD010429.pub2","article-title":"Treatment for osteoporosis in people with \u00df-thalassaemia","volume":"3","author":"Bhardwaj","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"CD005324","DOI":"10.1002\/14651858.CD005324.pub2","article-title":"Bisphosphonate therapy for children and adolescents with secondary osteoporosis","volume":"4","author":"Ward","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-SAT-LB052","article-title":"Intravenous bisphosphonate therapy in children with spinal muscular atrophy","volume":"3","author":"Nasomyont","year":"2019","journal-title":"J Endocr Soc."},{"key":"B103","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/cen.13537","article-title":"Effects of alendronate and alfacalcidol on bone in patients with MG initiating glucocorticoids treatment","volume":"88","author":"Lv","year":"2018","journal-title":"Clin Endocrinol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00198-014-2768-4","article-title":"Exacerbation of myasthenia gravis by alendronate","volume":"25","author":"Kesikburun","year":"2014","journal-title":"Osteoporos Int."},{"key":"B105","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/0022-3859.37525","article-title":"Risedronate induced transient ocular myasthenia","volume":"53","author":"Raja","year":"2007","journal-title":"J Postgrad Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s00198-012-1911-3","article-title":"The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy","volume":"23","author":"Sbrocchi","year":"2012","journal-title":"Osteoporos Int"},{"key":"B107","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1517\/21678707.2016.1148596","article-title":"Bisphosphonate use in Duchenne Muscular Dystrophy \u2013 why, when to start and when to stop?","volume":"4","author":"Wood","year":"2016","journal-title":"Expert Opinion on Orphan Drugs."},{"key":"B108","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1007\/s00198-016-3607-6","article-title":"Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis","volume":"27","author":"Beaudoin","year":"2016","journal-title":"Osteoporos Int."},{"key":"B110","first-page":"658","article-title":"denosumab treatment of severe disuse osteoporosis in a boy with spinal muscular atrophy","volume":"55","author":"Kutilek","year":"2017","journal-title":"Acta Med Iran."},{"key":"B111","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.2106\/JBJS.CC.17.00190","article-title":"Efficacy of denosumab for glucocorticoid-induced osteoporosis in an adolescent patient with duchenne muscular dystrophy: a case report","volume":"8","author":"Kumaki","year":"2018","journal-title":"JBJS Case Connect."},{"key":"B112","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/BOT.0b013e31828e13fe","article-title":"The role of recombinant PTH in human fracture healing: a systematic review","volume":"28","author":"Zhang","year":"2014","journal-title":"J Orthop Trauma"},{"key":"B113","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1530\/EJE-14-0865","article-title":"ENDOCRINOLOGY AND ADOLESCENCE: osteoporosis in children: diagnosis and management","volume":"173","author":"Saraff","year":"2015","journal-title":"Eur J End"},{"key":"B114","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1007\/s00198-016-3761-x","article-title":"Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report","volume":"27","author":"Catalano","year":"2016","journal-title":"Osteoporos Int."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00794\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T14:45:08Z","timestamp":1574433908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00794\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":114,"alternative-id":["10.3389\/fendo.2019.00794"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00794","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"article-number":"794"}}